Targeting Tim-1 to Circumvent Immune Tolerance in Prostate Cancer

doi 10.21236/ada547595
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Defense Technical Information Center

Related search

Targeting Host Factors to Circumvent Anti-Malarial Drug Resistance

Current Pharmaceutical Design
Drug DiscoveryPharmacology
2012English

Direct Therapeutic Targeting of Immune Checkpoint PD-1 in Pancreatic Cancer

British Journal of Cancer
Cancer ResearchOncology
2018English

Analysis of Tim-3 as a Therapeutic Target in Prostate Cancer

Tumor Biology
MedicineCancer Research
2017English

Targeting Cancer Stem Cells in Castration-Resistant Prostate Cancer

Clinical Cancer Research
Cancer ResearchOncology
2015English

Sigma1 Targeting to Suppress Aberrant Androgen Receptor Signaling in Prostate Cancer

Cancer Research
Cancer ResearchOncology
2017English

Targeting Tyrosine Kinases and Autophagy in Prostate Cancer

Hormones and Cancer
OncologyCancer ResearchEndocrinologyAutonomic SystemsEndocrineMetabolismDiabetes
2010English

Targeting AR Variant-Coactivator Interactions to Exploit Prostate Cancer Vulnerabilities

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2017English

Therapeutic Targeting of SPINK1-Positive Prostate Cancer

Science Translational Medicine
Medicine
2011English

Targeting CDK9: A Promising Therapeutic Opportunity in Prostate Cancer

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy